Data from CheckMate 064, 066 and 067 also found that elevated levels of IL-6 and CRP played both an indirect and a direct suppressive role, accounting for the poor outcomes of melanoma patients receiving single agent and combination checkpoint inhibition. This evidence concerns the gene CRP and melanoma.